CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
NCT00227344
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
129
Enrollment
INDUSTRY
Sponsor class
Stopped
Study prematurely terminated due to randomization imbalance.
Conditions
Atrial Fibrillation
Interventions
DEVICE:
RF ablation
DRUG:
Antiarrhythmic drugs
Sponsor
Biosense Webster EMEA